Remdesivir: Preliminary Data and Clinical Use Versus Recommended Use
- PMID: 33883244
- PMCID: PMC8085993
- DOI: 10.1542/peds.2021-050212
Remdesivir: Preliminary Data and Clinical Use Versus Recommended Use
Conflict of interest statement
POTENTIAL CONFLICT OF INTEREST: The authors have indicated they have no potential conflicts of interest to disclose.
Comment on
-
Compassionate Use of Remdesivir in Children With Severe COVID-19.Pediatrics. 2021 May;147(5):e2020047803. doi: 10.1542/peds.2020-047803. Pediatrics. 2021. PMID: 33883243
References
-
- Food and Drug Administration. Approves first treatment for COVID-19. 2020. Available at: https://www.fda.gov/news-events/press-announcements/fda-approves-first-t.... Accessed October 22, 2020
-
- Goldman DL, Aldrich ML, Hagmann SHF, et al. . Compassionate use of remdesivir in children with severe COVID-19. Pediatrics. 2021;147(5):e2020047803 - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources